Open access · CC-BY
via OpenAlex
Inflammatory Markers and Risk of Type 2 Diabetes
Xia Wang, Wei Bao, Jun Liu, Yingying Ouyang, Di Wang, Shuang Rong, Xiao Xiao, Zhilei Shan, Yan Zhang, Ping Yao, Liegang Liu
Diabetes Care · 2012 · ▲ 839 citations
Abstract
OBJECTIVE: There has been growing evidence that inflammatory markers play a role in the development of type 2 diabetes. We aimed to systematically review prospective studies on the associations of elevated levels of interleukin-6 (IL-6) and C-reactive protein (CRP) with increased risk of type 2 diabetes by conducting a meta-analysis. RESEARCH DESIGN AND METHODS: A systematic search of the PubMed, EMBASE, ISI Web of Knowledge, and Cochrane Library databases up until 10 February 2012 was conducted to retrieve prospective studies matched to search terms. We used generalized least-squares trend estimation to assess dose-response relationships. The summary risk estimates were pooled using either fixed-effects or random-effects models to incorporate between-study variation. RESULTS: The meta-analysis, including 10 prospective studies, with a total of 19,709 participants and 4,480 cases, detected a significant dose-response association of IL-6 levels with type 2 diabetes risk (relative risk [RR] 1.31 [95% CI 1.17-1.46]). For CRP, the meta-analysis involving 22 cohorts, with a total of 40,735 participants and 5,753 cases, showed that elevated CRP levels were significantly associated with increased risk of type 2 diabetes (1.26 [1.16-1.37]), with the absence of publication bias. Sensitivity and subgroup analyses further supported the associations. CONCLUSIONS: This meta-analysis provides further evidence that elevated levels of IL-6 and CRP are significantly associated with increased risk of type 2 diabetes.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.2337/dc12-0702
- Canonical
- link ↗
- Fetched
- 2026-07-28 MST
Cite this
APA
Wang, X., Bao, W., Liu, J., Ouyang, Y., Wang, D., Rong, S., Xiao, X., Shan, Z., Zhang, Y., Yao, P., & Liu, L. (2012). Inflammatory Markers and Risk of Type 2 Diabetes. <em>Diabetes Care</em>. https://doi.org/10.2337/dc12-0702
Vancouver
Wang X, Bao W, Liu J, Ouyang Y, Wang D, Rong S, et al. Inflammatory Markers and Risk of Type 2 Diabetes. Diabetes Care. 2012. doi:10.2337/dc12-0702.
BibTeX
@article{xia2012Inflam,
title = {Inflammatory Markers and Risk of Type 2 Diabetes},
author = {Xia Wang and Wei Bao and Jun Liu and Yingying Ouyang and Di Wang and Shuang Rong and Xiao Xiao and Zhilei Shan and Yan Zhang and Ping Yao and Liegang Liu},
journal = {Diabetes Care},
year = {2012},
doi = {10.2337/dc12-0702},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Canadian Journal of Infectious Diseases and Medical Microbiology 2022
Open access · CC-BY
Elevated Salivary Inflammatory Biomarkers are Associated with SARS-CoV-2 Infection Severity
Translational Pediatrics 2026
Open access · CC-BY
Inflammatory cytokines as biomarkers for disease severity in pediatric viral pneumonia: a systematic review and meta-analysis
Bratislavské lekárske listy/Bratislava medical journal 2026
Open access · OA
Predictive Role of Maternal Mid-Gestational Inflammatory Biomarkers in Preterm Birth: A Prospective Cohort Study
Frontiers in Cardiovascular Medicine 2023
Open access · CC-BY
Inflammation biomarkers are associated with the incidence of cardiovascular disease: a meta-analysis
Frontiers in Physiology 2021
Open access · CC-BY
Calorie Restriction With Exercise Intervention Improves Inflammatory Response in Overweight and Obese Adults: A Systematic Review and Meta-Analysis
BMC Oral Health 2021
Open access · CC-BY